CSPC Pharmaceutical Group Ltd Financials

Market Capitalization HK$90.35 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	22.78
Forward PE	16.71
Price to Sales TTM	HK$3.67
Price to Book MRQ	HK$2.60
Enterprise to Revenue	3.38
Enterprise to EBITDA	16.36

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	15.49%
Operating Margin	13.14%
Return on Assets TTM	9.75%
Return on Equity TTM	12.78%

Income Statement

Revenue TTM	HK$29,196,565,939
Revenue per Share TTM	HK$2.29
Quarterly Revenue Growth	3.40%
Gross Profit TTM	HK$19,337,723,954
EBITDA	HK$7,753,898,560
Net Income to Common TTM	HK$4,523,446,445
Diluted EPS TTM	HK$0.37
Quarterly Earnings Growth YoY	27.20%

Balance Sheet

Total Cash MRQ	HK$10,807,390,531
Total Cash per Share MRQ	HK$0.85
Total Debt MRQ	HK$
Total Debt to Equity MRQ	1.42
Current Ratio MRQ	2.24
Book Value per Share MRQ	HK$3.24

Cash Flow

Operating Cash Flow TTM	HK$5,756,992,483
Levered Free Cash Flow TTM	HK$4,820,435,541

1093 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	11,418,751,732
Float Shares	7,766,320,940
Avg 10 Volume	151,784,914
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	31.52%
% Held by Institutions	30.18%

Stock Price Summary

Beta	0.86
Fifty Two Week Low	HK$4.27
Fifty Two Week High	HK$11.63
Fifty Two Week Change	46.23%
Day 50 MA	HK$7.85
Day 200 MA	HK$8.06

Dividends and Splits

Forward Annual Dividend Rate	HK$0.28
Forward Annual Dividend Yield	3.30%
Trailing Annual Dividend Rate	HK$0.24
Trailing Annual Dividend Yield	2.83%
Payout Ratio	70.85%
Dividend Date
Ex Dividend Date	2025-10-17
Last Split Factor
Last Split Date	2020-10-16